Experimental Hematology

Slides:



Advertisements
Similar presentations
Previous Estimates of Mitochondrial DNA Mutation Level Variance Did Not Account for Sampling Error: Comparing the mtDNA Genetic Bottleneck in Mice and.
Advertisements

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.
Oxidative stress and hypoxia in normal and leukemic stem cells Ugo Testa, Catherine Labbaye, Germana Castelli, Elvira Pelosi Experimental Hematology Volume.
Evidence of B Cell Immune Responses to Acute Lymphoblastic Leukemia in Murine Allogeneic Hematopoietic Stem Cell Transplantation Recipients Treated with.
GSK3β inhibition activates the CDX/HOX pathway and promotes hemogenic endothelial progenitor differentiation from human pluripotent stem cells Kenji Kitajima,
My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:
National Guidelines for Nursing Delegation
Fever, Skin Eruption, Low Serum Gammaglobulin in a Child with Leukemia
Transcriptional activation by MLL fusion proteins in leukemogenesis
Tessa Laurie Holyoake, (March 17, 1963 – August 30, 2017): Remembering a life that knew no boundaries  Connie J. Eaves, PhD, FRS(C), Corresponding FRS.
Ling Guo, Robert C.H. Zhao, Yaojiong Wu  Experimental Hematology 
Successful Remission Rates and Survival after Lymphodepleting Chemotherapy and Donor Lymphocyte Infusion for Relapsed Hematologic Malignancies Postallogeneic.
Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial.
William L. Lanier, MD  Mayo Clinic Proceedings 
Nishitha M. Reddy, Olalekan Oluwole, John P. Greer, Brian G
Cassie J. Clarke, Tessa L. Holyoake  Experimental Hematology 
Experimental Hematology
Velizar Shivarov, Lars Bullinger  Experimental Hematology 
Ya-Huei Kuo, Jing Qi, Guerry J. Cook  Experimental Hematology 
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without.
Donor CD3+ lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: Single-center experience  Jean El-Cheikh, Roberto.
Purification of CD4+ T Cells for Adoptive Immunotherapy after Allogeneic Hematopoietic Stem Cell Transplantation  Evgeny Klyuchnikov, Andreas Sputtek,
Kinetics and symmetry of divisions of hematopoietic stem cells
Getting blood from bone: An emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche  Yusuke.
Tracy L. Farrell, Timothy R. McGuire, Laura D. Bilek, Susan K
Stem cell plasticity: Recapping the decade, mapping the future
Carol Ann Huff, Ephraim J. Fuchs, B
Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease–Guided Multiple DLIs Could Improve Outcomes.
Gender Differences Among Long-Distance Backpackers: A Prospective Study of Women Appalachian Trail Backpackers  David R. Boulware, MD  Wilderness & Environmental.
Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions  Darius Sairafi, Mats Remberger, Michael.
Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial.
A Phase I/II Study of Chemotherapy Followed by Donor Lymphocyte Infusion plus Interleukin-2 for Relapsed Acute Leukemia after Allogeneic Hematopoietic.
High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation.
Samson Phan, MS, John Lissoway, MD, Grant S. Lipman, MD 
Xiaoou Zhou, Malcolm K. Brenner  Experimental Hematology 
Christopher E. Schmitt, Carlos O. Lizama, Ann C. Zovein 
Pathogenesis of myeloproliferative neoplasms
Experimental Hematology
Eun-ju Lee, Pankaj Godara, David Haylock  Experimental Hematology 
A dual role of Erk signaling in embryonic stem cells
Remembering Ihor Lemischka—The scientist's scientist
Volume 61, Issue 4, Pages (April 2002)
High Alloreactivity of Low-Dose Prophylactic Donor Lymphocyte Infusion in Patients with Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host.
Optimizing autologous cell grafts to improve stem cell gene therapy
Inside This Issue Experimental Hematology
Mohammad Alhyari, M. D. , Aymen Bukannan, M. D. , Kimberly Brown, M. D
Sietske T. Bakker, Emmanuelle Passegué  Experimental Hematology 
Tumor necrosis factor α in the onset and progression of leukemia
Pharmacological activation of wild-type p53 in the therapy of leukemia
CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50.
Organization news Archives of Physical Medicine and Rehabilitation
In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)
Kinase signaling and targeted therapy for primary myelofibrosis
Outcome of Donor Lymphocyte Infusion after T Cell–depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic.
Ashley A. Newcombe, Brenda E.S. Gibson, Karen Keeshan 
Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post- Transplantation Cyclophosphamide-Based Haploidentical Transplantation with.
Zsolt P. Nagy, M. D. , Ph. D. , Laura F. Rienzi, Ph. D. , Filippo M
Preoperative Smoking Cessation: The Role of the Primary Care Provider
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Stem cell biology and the plasticity polemic
Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic.
Treatment versus Transplant for Challenging Hematologic Disorders
Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation 
Volume 14, Issue 1, (January 2017)
Long-term persistent lymphopenia in hematopoietic stem cell donors after donation for donor lymphocyte infusion  Franck E. Nicolini, Eric Wattel, Anne-Sophie.
Attitudes and predictive factors for live kidney donation: A comparison of live kidney donors versus nondonors  Lynn Stothers, William A. Gourlay, Li.
Pediatric leukemia: Moving toward more accurate models
In This Issue Cell Volume 145, Issue 3, (April 2011)
Graft Versus Leukemia Effect Is Overestimated in Studies with High Rates of Graft Versus Host Disease Related Mortality: A Simulation Study  Murtadha.
Presentation transcript:

Experimental Hematology Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect  Guillermo Orti, Pere Barba, Laura Fox, Olga Salamero, Francesc Bosch, David Valcarcel  Experimental Hematology  Volume 48, Pages 1-11 (April 2017) DOI: 10.1016/j.exphem.2016.12.004 Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions

Figure 1 Diagram displaying the use of therapeutic DLI (tDLI), preemtive DLI (pDLI) and prophylactic DLI (prDLI). Experimental Hematology 2017 48, 1-11DOI: (10.1016/j.exphem.2016.12.004) Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.